The Food and Drugs Authority (FDA) has allayed public fears of blood clotting in the body upon receiving an AstraZeneca vaccine shot to build immunity against Covid-19.
According to the FDA, a robust safety monitoring system of the vaccine by a constituted committee of experts known as the Joint Covid-19 Vaccine Safety Review Committee (JCVSRC), currently has established no causal link between blood clotting and the AstraZeneca vaccine.
A position also upheld by the World Health Organization (WHO) and the European Medicines Agency.
The most common side effects of taking a shot of the vaccine are however; headaches, fever, chills, body pains among others which the JCVSRC posits are expected from the vaccination in most cases and are resolved in a day or two.
Despite not recording any reported case of blood clotting linked to the AstraZeneca vaccine in the country, the FDA noted that it will however, continue to closely monitor the situation.
Find below details of the FDA’s press release on blood clotting assertions linked to the AstraZeneca vaccine:
